Monday, August 24, 2009

Cloud Services for Biopharma R&D

Fierce Biotech reports today that Biopharma research and development organzations need to be mindful when purchasing a cloud computing service.

Cloud computing--a data-crunching force multiplier that allows companies to draw on resources across the Internet, either on the fly or as a dedicated service--is potentially disruptive to companies because it changes the dynamic of who owns the capital assets, turning traditional IT infrastructure models on their heads.

Share this article with your social network, just click below to share now!

No comments :

Post a Comment